Olive is currently the Senior Administrative Director of the Connell & O'Reilly Families, Cell Manipulation Core Facility at Dana Farber Cancer Institute in Boston Massachusetts. Prior to this postion she served as the Quality and Regulatory Director the Cell Therapy Programs at DFCI for the first 15 of her 20+ years at DFCI. Olive is very active in several professional organizations; FACT, ISCT, MABB and AABB and serves on a variety of quality and regulatory committees and boards.
Olive has 30 plus years in blood banking, clinical laboratory management and cellular manufacturing. In her current role she is directly responsible for the Financial and Administrative oversight for the GMP manufacturing lab. The DFCI-CMCF laboratory manufactures a variety of both HCT/P and investigational cell therapy products and has a robust Cell Therapy Testing Laboratory to support the program. In addition, Olive works with investigators and facilitates the technology transfer of projects and works to maintain project timelines, tracking progress against goals, coordinates with Quality Assurance and technical experts to fulfill program’s contracts.
Olive also serves as the Quality Assurance Director for DFCI’s contracted transfusion services and as a quality and regulatory advisor for the Brigham and Women's Hospital IVF’s Laboratory. She is an accreditation inspector for AABB, CAP and FACT and provides technical, quality and regulatory guidance for both blood banks, cellular therapy and tissue related programs.
• Olive is actively involved in several professional organizations; FACT, ISCT, MABB and AABB and serves on a variety of quality and regulatory committees and boards. She also serves a regulatory consultant for both clinical laboratories and other cellular therapy and tissue related programs.
